Three-Dimensional Quantitative Structure−Activity Relationship Studies on Selected MT1and MT2Melatonin Receptor Ligands:  Requirements for Subtype Selectivity and Intrinsic Activity Modulation

Journal of Medicinal Chemistry
2003.0

Abstract

The three-dimensional quantitative structure-activity relationship comparative molecular field analysis (3D-QSAR CoMFA) approach was applied to some classes of melatonin (MLT) membrane receptor ligands, with the principal aim of exploring the correlation between their steric features and MT(2)-selective antagonism. Binding data obtained from cloned MT(1) and MT(2) receptor subtypes were used to develop 3D-QSAR models for agonists and for antagonists at the two receptor subtypes, looking for the structural requirements for receptor subtype selectivity. In particular, we superposed the compounds showing antagonist activity, or very low intrinsic activity at the GTPgammaS test, following the hypothesis that the occupation of an additional pocket positioned out of the plane of MLT is one of the major determinants for MT(2) selectivity; the statistical models obtained confirmed this hypothesis. Structure-intrinsic activity relationship studies, applied to a set of compounds homogeneously tested, allowed the identification of the structural features whose modulation shifts the behavior from that of the agonist to that of the antagonist. The pocket out of the plane of MLT was identified as one of the key features for obtaining selective MT(2) antagonists. The reliability of our statistical models was further confirmed by the correct prediction of the pharmacological behavior of some N-substituted melatonin derivatives, which were prepared and tested on cloned receptor subtypes.

Knowledge Graph

Similar Paper

Three-Dimensional Quantitative Structure−Activity Relationship Studies on Selected MT<sub>1</sub>and MT<sub>2</sub>Melatonin Receptor Ligands:  Requirements for Subtype Selectivity and Intrinsic Activity Modulation
Journal of Medicinal Chemistry 2003.0
Analysis of Structure−Activity Relationships for MT<sub>2</sub> Selective Antagonists by Melatonin MT<sub>1</sub> and MT<sub>2</sub> Receptor Models
Journal of Medicinal Chemistry 2005.0
Three-Dimensional Quantitative Structure−Activity Relationship of Melatonin Receptor Ligands:  A Comparative Molecular Field Analysis Study
Journal of Medicinal Chemistry 1997.0
Melatonin Receptor Ligands:  Synthesis of New Melatonin Derivatives and Comprehensive Comparative Molecular Field Analysis (CoMFA) Study
Journal of Medicinal Chemistry 1998.0
Design and Synthesis ofN-(3,3-Diphenylpropenyl)alkanamides as a Novel Class of High-Affinity MT<sub>2</sub>-Selective Melatonin Receptor Ligands
Journal of Medicinal Chemistry 2006.0
Synthesis and Structure−Affinity−Activity Relationships of Novel Benzofuran Derivatives as MT<sub>2</sub> Melatonin Receptor Selective Ligands
Journal of Medicinal Chemistry 2002.0
Pharmacophoric Search and 3D-QSAR Comparative Molecular Field Analysis Studies on Agonists of Melatonin Sheep Receptors
Journal of Medicinal Chemistry 1998.0
N-(Substituted-anilinoethyl)amides: Design, Synthesis, and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands
Journal of Medicinal Chemistry 2007.0
2-N-Acylaminoalkylindoles:  Design and Quantitative Structure−Activity Relationship Studies Leading to MT<sub>2</sub>-Selective Melatonin Antagonists
Journal of Medicinal Chemistry 2001.0
Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: Synthesis, binding affinity and intrinsic activity for MT1 and MT2 melatonin receptors
Bioorganic &amp; Medicinal Chemistry 2011.0